Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Alibaba Health Information Technology Ltd is an investment holding company. The company is primarily engaged in pharmaceutical direct business, operation of pharmaceutical e-commerce platform, consumer healthcare services platform, provision of tracking and digital health business, and internet healthcare business. Through the pharmaceutical direct business, the group provides customers with a wide range of products with strict quality control, including prescription drugs, over-the-counter (OTC) drugs, health supplements, medical devices, contact lenses, and skincare. It generates maximum revenue from Pharmaceutical direct business. Geographically, it derives a majority of revenue from Mainland China.
Beijing, 100102, Bermuda